Thrivent Financial For Lutherans Biogen Inc. Transaction History

Thrivent Financial For Lutherans

$52.6 Billion
Q3 2024

A detailed history of Thrivent Financial For Lutherans transactions in Biogen Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 188,653 shares of BIIB stock, worth $28.9 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

188,653

Previous 192,507 2.0%

Holding current value

$28.9 Million

Previous $44.6 Million 18.06%

% of portfolio

0.07%

Previous 0.09%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$189.07 - $236.8 $728,675 - $912,627	-3,854 Reduced 2.0%	188,653 $36.6 Million
Q2 2024 Aug 13, 2024	SELL	$190.52 - $236.72 $1.69 Million - $2.1 Million	-8,889 Reduced 4.41%	192,507 $44.6 Million
Q1 2024 May 14, 2024	SELL	$212.02 - $267.71 $12.3 Million - $15.5 Million	-57,961 Reduced 22.35%	201,396 $43.4 Million
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $4.74 Million - $5.7 Million	-21,290 Reduced 7.59%	259,357 $67.1 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $2.19 Million - $2.47 Million	-8,657 Reduced 2.99%	280,647 $72.1 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $2.16 Million - $2.49 Million	-7,838 Reduced 2.64%	289,304 $82.4 Million
Q1 2023 May 17, 2023	SELL	$256.56 - $292.34 $376,116 - $428,570	-1,466 Reduced 0.49%	297,142 $82.6 Million
Q4 2022 Feb 08, 2023	SELL	$252.44 - $306.72 $2.58 Million - $3.13 Million	-10,214 Reduced 3.31%	298,608 $82.7 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $9.24 Million - $12.7 Million	47,482 Added 18.17%	308,822 $82.5 Million
Q2 2022 Aug 16, 2022	SELL	$187.54 - $223.02 $1.67 Million - $1.99 Million	-8,904 Reduced 3.29%	261,340 $53.3 Million
Q1 2022 May 13, 2022	BUY	$193.77 - $244.14 $2.13 Million - $2.68 Million	10,967 Added 4.23%	270,244 $56.9 Million
Q4 2021 Feb 16, 2022	BUY	$223.92 - $287.77 $7.09 Million - $9.11 Million	31,661 Added 13.91%	259,277 $62.2 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $10.6 Million - $13.8 Million	37,331 Added 19.62%	227,616 $64.4 Million
Q2 2021 Aug 19, 2021	BUY	$259.0 - $414.71 $7.69 Million - $12.3 Million	29,693 Added 18.49%	190,285 $65.9 Million
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $1.75 Million - $2.05 Million	7,208 Added 4.7%	160,592 $44.9 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $1.52 Million - $2.29 Million	-6,441 Reduced 4.03%	153,384 $37.6 Million
Q3 2020 Nov 10, 2020	SELL	$264.77 - $305.71 $1.85 Million - $2.13 Million	-6,971 Reduced 4.18%	159,825 $45.3 Million
Q2 2020 Aug 12, 2020	SELL	$258.66 - $342.55 $1 Million - $1.33 Million	-3,871 Reduced 2.27%	166,796 $44.6 Million
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $21.4 Million - $27.2 Million	79,761 Added 87.74%	170,667 $54 Million
Q4 2019 Feb 13, 2020	BUY	$220.06 - $304.07 $2.49 Million - $3.45 Million	11,337 Added 14.25%	90,906 $27 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $7.59 Million - $8.51 Million	-34,912 Reduced 30.5%	79,569 $18.5 Million
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $34.3 Million - $37.8 Million	-156,478 Reduced 57.75%	114,481 $26.8 Million
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $37.7 Million - $59 Million	-174,100 Reduced 39.12%	270,959 $64.1 Million
Q4 2018 Feb 15, 2019	BUY	$278.5 - $352.75 $3.79 Million - $4.81 Million	13,623 Added 3.16%	445,059 $134 Million
Q3 2018 Nov 15, 2018	SELL	$293.51 - $383.83 $1.05 Million - $1.37 Million	-3,571 Reduced 0.82%	431,436 $152 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $37.1 Million - $44.2 Million	143,962 Added 49.46%	435,007 $126 Million
Q1 2018 May 08, 2018	SELL	$260.13 - $367.91 $4.79 Million - $6.78 Million	-18,425 Reduced 5.95%	291,045 $79.7 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $230,114 - $257,745	-748 Reduced 0.24%	309,470 $98.6 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $87.2 Million - $102 Million	310,218	310,218 $97.1 Million

Others Institutions Holding BIIB

# of Institutions

1,035

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account

Thrivent Financial For Lutherans Biogen Inc. Transaction History